NCT03480360 Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03467867 A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03447808 Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03438344 Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant Status WITHDRAWN Phase PHASE2
NCT03436771 Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product Status TERMINATED Phase N/A
NCT03422393 Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03379051 Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL Status TERMINATED Phase PHASE1/PHASE2
NCT03374137 Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia Status COMPLETED Phase N/A
NCT03370185 Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma Status WITHDRAWN Phase PHASE2
NCT03336333 A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03333486 Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer Status TERMINATED Phase PHASE2
NCT03328273 A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03316209 Identification of Occupational Exposures in Acute Hematologic Malignancy Status COMPLETED Phase N/A
NCT03314974 Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders Status RECRUITING Phase PHASE2
NCT03310190 Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice Status COMPLETED Phase N/A